False Claims Act/Whistleblower Investigations
Companies doing business with federal and state governments — particularly in the healthcare, defense contracting, energy, and financial services industries — face ever-increasing scrutiny from government regulators and whistleblowers. Central to this legal environment are the federal False Claims Act (“FCA”) and its state-level analogues. These statutes allow cases to be initiated by whistleblowers for treble damages and civil penalties and have led to settlements and judgments in the billions of dollars.
King & Spalding’s False Claims Act experience ranges from high-profile criminal and civil fraud and abuse matters to private, internal corporate compliance and employment issues. In cases requiring delicate interaction with, or a voluntary disclosure to, regulators or an aggressive litigation stance at trial or on appeal, our team is prepared to vigorously defend clients against FCA claims in any context.
October 14, 2024
United States District Court in Florida Holds False Claims Act Qui Tam Provision Unconstitutional
October 10, 2024
United States District Court in Florida Holds False Claims Act Qui Tam Provision Unconstitutional
August 8, 2024
DOJ Announces Corporate Whistleblower Awards Pilot Program
September 25, 2024
Former federal prosecutor Michael Galdo joins in Austin as counsel to bolster the firm’s government investigations, cybersecurity and national security services
September 18, 2024
Jim Boswell, Michael Paulhus and Jennifer Lewin obtain a favorable dismissal on behalf of Cancer Provider in a whistleblower case before a New York federal court
September 9, 2024
Prominent Trial Lawyer Will Stute Joins King & Spalding’s Product Liability and Mass Torts Practice Group in Miami